Socioeconomic Status Differences in Hormone Therapy

American Journal of Epidemiology

Volumn 148, Issue 6, 1998, Pages 581-593

  Marks, Nadine F ^a   Shinberg, Diane S ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Department of Political Science   (United States)

Author keywords

Estrogen replacement therapy; Hormones; Menopause; Social class; Women

Indexed keywords

ARTICLE; BODY MASS; EDUCATIONAL STATUS; ESTROGEN THERAPY; FEMALE; HEALTH BEHAVIOR; HUMAN; INCOME; LONGITUDINAL STUDY; MENOPAUSE; MIDDLE AGED; OCCUPATION; RISK; SOCIAL CLASS; SOCIOECONOMICS; STATISTICS; UNITED STATES;

BODY MASS INDEX; EDUCATIONAL STATUS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH BEHAVIOR; HUMANS; INCOME; LONGITUDINAL STUDIES; MENOPAUSE; MIDDLE AGED; OCCUPATIONS; ODDS RATIO; SOCIAL CLASS; SOCIOECONOMIC FACTORS; WISCONSIN;

EID: 0032529931     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009684     Document Type: Article

References (71)

1. Thompson W. Estrogen replacement therapy in practice: trends and issues. Am J Obstet Gynecol 1995;173(suppl 3): 990-3.
2. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536-45.
3. Derby CA, Hume AL, Barbour MM, et al. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am J Epidemiol 1993;137:1125-35.
4. Barrett-Connor E, Wingard DL, Criqui MH. Postmenopausal estrogen use and heart disease risk factors in the 1980s. JAMA 1989;261:2095-100.
5. Standeven M, Criqui MH, Klauber MR, et al. Correlates of change in postmenopausal estrogen use in a population-based study. Am J Epidemiol 1986;124:268-74.
6. Johannes CB, Crawford SL, Posner JG, et al. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol 1994;140:439-52.
7. National Center for Health Statistics. National Ambulatory Medical Care Survey: 1992. Hyattsville, MD: National Center for Health Statistics, 1995. (CD-ROM, series 13, no. 4).
8. Soffa VM. Alternatives to hormone replacement for menopause. Altern Ther Health Med 1996;2:34-9.
9. Auerbach JD, Figert AE. Women's health research: public policy and sociology. J Health Soc Behav 1995;(special issue):115-31.
10. Lewis J. Feminism, the menopause and hormone replacement therapy. Feminist Rev 1993;43:38-56.
11. Lock M. The politics of mid-life and menopause: ideologies for the second sex in North America and Japan. In: Lindenbaum S, Lock M, eds. Knowledge, power, and practice: the anthropology of medicine and everyday life. Berkeley, CA: University of California Press, 1993:330-63.
12. MacPherson K. False promises of hormone replacement therapy and current dilemmas. In: Callahan JC, ed. Menopause: a midlife passage. Indianapolis, IN: Indiana University Press, 1993:145-59.
13. National Women's Health Network. Taking hormones and women's health: choices, risks, benefits. Washington, DC: National Women's Health Network, 1989.
14. McCrea FB. The politics of menopause: the "discovery" of a deficiency disease. Soc Problems 1983;31:111-23.
15. MacPherson KI. Menopause as disease: the social construction of a metaphor. ANS Adv Nurs Sci 1981;3:95-113.
16. Colditz GA. Controversies in science: hormone replacement therapy: the benefits of hormone replacement therapy do not outweigh the increased risk of breast cancer. J NIH Res 1996;8:41-2.
17. Stanford JL. Controversies in science. Hormone replacement therapy: the benefits of hormone replacement therapy outweigh the breast-cancer risks for some women. J NIH Res 1996;8:40-1.
18. Rosenberg L. Hormone replacement therapy: the need for reconsideration. Am J Public Health 1993;83:1670-3.
19. US Congress, Office of Technology Assessment. The menopause, hormone therapy, and women's health. Washington, DC: US GPO, 1992. (Publication no. OTA-BP-BA-88).
20. Ettinger B, Grady D. The waning effect of postmenopausal estrogen therapy on osteoporosis. (Editorial). N Engl J Med 1993;329:1192-3.
21. Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199-208.
22. Matthews KA, Kuller LH, Wing RR, et al. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 1996;143:971-8.
23. Matthews KA. Health prior to hormone use: Matthews et al. reply to Grodstein. Am J Epidemiol 1996;143:983-4.
24. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
25. Steinberg KK, Smith SJ, Thacker SB, et al. Breast cancer risk and duration of estrogen use: the role of study design in meta-analysis. Epidemiology 1994;5:415-21.
26. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985;102:319-24.
27. Lindsay R, Hart DM, Forrest C, et al. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980;2: 1151-4.
28. Bush TL, Barrett-Connor E. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev 1985;7:80-104.
29. Rosenberg L, Shapiro S, Kaufman DW, et al. Patterns and determinants of conjugated estrogen use. Am J Epidemiol 1979;109:676-86.
30. Stadel BV, Weiss N. Characteristics of menopausal women: a survey of King and Pierce counties in Washington, 1973-1974. Am J Epidemiol 1975;102:209-16.
31. Keating NL, Cleary PD, Rossi AS, et al. Use of hormone replacement therapy in a national sample of postmenopausal women. Presented at the 20th annual meeting of the Society of General Internal Medicine, Washington, DC, May 1997.
32. House JS, Lepkowski JM, Kinney AM, et al. The social stratification of aging and health. J Health Soc Behav 1994; 35:213-34.
33. Adler NE, Boyce WT, Chesney MA, et al. Socioeconomic inequalities in health: no easy solution. JAMA 1993;269: 3140-5.
34. Feinstein JS. The relationship between socioeconomic status and health: a review of the literature. Milbank Q 1993;71: 279-322.
35. Waldron I. Patterns and causes of gender differences in smoking. Soc Sci Med 1991;32:989-1005.
36. House JS, Kessler RC, Herzog AR, et al. Age, socioeconomic status, and health. Milbank Q 1990;68:383-411.
37. Longino CF, Warheit GJ, Green JA. Class, aging, and health. In: Markides KS, ed. Aging and health: perspectives on gender, race, ethnicity, and class. Newbury Park, CA: Sage Publications, 1989:79-109.
38. Marmot MG, Kogevinas M, Elston MA. Social/economic status and disease. Annu Rev Public Health 1987;8:111-35.
39. Syme SL, Berkman LF. Social class, susceptibility and sickness. Am J Epidemiol 1976;104:1-8.
40. Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav 1995;36: 1-10.
41. Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav 1995;(special issue):80-94.
42. McLeod JD, Kessler RC. Socioeconomic status differences in vulnerability to undesirable life events. J Health Soc Behav 1990;31:162-72.
43. Mechanic D. Socioeconomic status and health: an examination of underlying processes. In: Bunker JP, Gomby DS, Kehrer BH, eds. Pathways to health: the role of social factors. Menlo Park, CA: The Henry J. Kaiser Family Foundation, 1989:9-26.
44. Kessler RC. A disaggregation of the relationship between socioeconomic status and psychological distress. Am Sociol Rev 1982;47:752-64.
45. Marks NF. Socioeconomic status, gender, and health at midlife: evidence from the Wisconsin Longitudinal Study. In: Kronenfeld JJ, ed. Health care delivery system changes: new roles for providers, insurers, and patients. (Research in the sociology of health care, vol 13). Greenwich, CT: JAI Press, 1996:135-52.
46. Leigh JP. Multidisciplinary findings on socioeconomic status and health. (Letter). Am J Public Health 1993;83:289-90.
47. Winkleby MA, Jatulis DE, Frank E, et al. Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health 1992;82:816-20.
48. Krieger N, Fee E. Social class: the missing link in U.S. health data. Int J Health Serv 1994;24:25-44.
49. Lee PR, Moss N, Krieger N. Measuring social inequalities in health: report on the conference of the National Institutes of Health. Public Health Rep 1995;110:302-5.
50. Arber S. Measuring social inequalities in health for different population groups: limitations and opportunities in current measures. Presented at the Measuring Social Inequalities in Health conference, National Institutes of Health, Annapolis, Maryland, September 1994.
51. Egeland GM, Matthews KA, Kuller LH, et al. Characteristics of noncontraceptive hormone users. Prev Med 1988;17:403-11.
52. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
53. Grodstein F. Invited commentary: Can selection bias explain the cardiovascular benefits of estrogen replacement therapy? Am J Epidemiol 1996;143:979-82.
54. Hauser RM, Carr D, Hauser TS, et al. The class of 1957 after 35 years: overview and preliminary findings. Madison, WI: Center for Demography and Ecology, University of Wisconsin-Madison, 1994. (CDE working paper no. 93-17, revised).
55. Pokras R, Hufnagel VG. Hysterectomies in the United States, 1965-84. Hyattsville, MD: National Center for Health Statistics, 1987. (Vital and Health Statistics, series 13, no. 92) (DHHS publication no. (PHS) 88-1753).
56. Hauser RM, Warren JR. A socioeconomic index for occupations in the 1990 Census. Madison, WI: Center for Demography and Ecology, University of Wisconsin-Madison, 1996. (CDE working paper no. 96-01).
57. Stevens G, Featherman DL. A revised socioeconomic index of occupational status. Soc Sci Res 1982;8:201-21.
58. Hauser RM, Featherman DL. The process of stratification: trends and analyses. New York, NY: Academic Press, Inc, 1977.
59. Santow G, Bracher M. Correlates of hysterectomy in Australia. Soc Sci Med 1992;34:929-42.
60. Kjerulff K, Langenberg P, Guzinski G. The socioeconomic correlates of hysterectomies in the United States. Am J Public Health 1993;83:106-8.
61. Meilahn EN, Matthews KA, Egeland G, et al. Characteristics of women with hysterectomy. Maturitas 1989;11:319-29.
62. Marks NF, Shinberg DS. Socioeconomic differences in hysterectomy: The Wisconsin Longitudinal Study. Am J Public Health 1997;87:1507-14.
63. Shinberg DS. An event history analysis of age at last menstrual period: correlates of natural and surgical menopause among midlife Wisconsin women. Soc Sci Med 1998;46: 1381-96.
64. Kominski R, Adams A. Educational attainment in the United States: March 1991 and 1990. (Current population reports: population characteristics, series P-20, no. 462). Washington, DC: US GPO, 1992.
65. Marmot MG, Smith GD, Stansfeld S, et al. Health inequalities among British civil servants: The Whitehall II Study. Lancet 1991;337:1387-93.
66. Worcester N, Whatley MH. The selling of HRT: playing on the fear factor. Feminist Rev 1992;41:1-26.
67. Goodman M. Toward a biology of menopause. Signs 1980;5: 739-53.
68. Wilson RA. Feminine forever. New York, NY: M. Evans, 1966.
69. Wilson RA, Wilson TA. The fate of the nontreated postmenopausal woman: a plea for the maintenance of adequate estrogen from puberty to the grave. J Am Geriatr Soc 1963;11:347-62.
70. Umberson D. Gender, marital status and the social control of health behavior. Soc Sci Med 1992;34:907-17.
71. Umberson D. Family status and health behaviors: social control as a dimension of social integration. J Health Soc Behav 1987;28:306-19.